Question 1

What is the catalog number for JUN, phosphorylated (Ser63) (Transcription Factor AP-1, Activator Protein 1, AP1, Proto-oncogene c-jun, V-jun Avian Sarcoma Virus 17 Oncogene Homolog, p39, JUN) (PE) discontinued?

Accepted Answer

The catalog number for JUN, phosphorylated (Ser63) (Transcription Factor AP-1, Activator Protein 1, AP1, Proto-oncogene c-jun, V-jun Avian Sarcoma Virus 17 Oncogene Homolog, p39, JUN) (PE) discontinued is J7998-03J-PE.

Question 2

What sizes are available for JUN, phosphorylated (Ser63) (Transcription Factor AP-1, Activator Protein 1, AP1, Proto-oncogene c-jun, V-jun Avian Sarcoma Virus 17 Oncogene Homolog, p39, JUN) (PE) discontinued?

Accepted Answer

JUN, phosphorylated (Ser63) (Transcription Factor AP-1, Activator Protein 1, AP1, Proto-oncogene c-jun, V-jun Avian Sarcoma Virus 17 Oncogene Homolog, p39, JUN) (PE) discontinued

Selected Variant

J7998-03J-PE

Size: 200 µL

Product Specifications

Clonality

Pab

Question 3

Is JUN, phosphorylated (Ser63) (Transcription Factor AP-1, Activator Protein 1, AP1, Proto-oncogene c-jun, V-jun Avian Sarcoma Virus 17 Oncogene Homolog, p39, JUN) (PE) discontinued in stock?

Accepted Answer

JUN, phosphorylated (Ser63) (Transcription Factor AP-1, Activator Protein 1, AP1, Proto-oncogene c-jun, V-jun Avian Sarcoma Virus 17 Oncogene Homolog, p39, JUN) (PE) discontinued

Selected Variant

J7998-03J-PE

Size: 200 µL

Product Specifications

Clonality

Pab

Question 4

What dilution range is recommended for immunohistochemistry (IHC) with this antibody?

Accepted Answer

A starting IHC dilution range is listed on the datasheet, but should be optimized for your specific tissue type and staining protocol.

Question 5

Can I request a Safety Data Sheet (SDS) for this product?

Accepted Answer

Yes, safety data sheets are available for hazardous or chemically classified products and can be provided on request or downloaded from the product page.

Question 6

Can this product be used for co-immunoprecipitation (Co-IP)?

Accepted Answer

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.